Evidence map›Paper›PMID 26807159›Full record

ArticleDiabetology & metabolic syndrome2016

Juçara pulp supplementation improves glucose tolerance in mice.

L M Oyama, F P Silva, J Carnier, D A de Miranda, A B Santamarina, E B Ribeiro, C M Oller do Nascimento, V V de Rosso

Open access · goldAbstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Effects of Juçara (Nutrients · 2023
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Polyphenols-Rich Fruit (Molecules (Basel, Switzerland) · 2019
    Article
  11. Review
  12. The Use of Juçara (Molecules (Basel, Switzerland) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

L M OyamaDepartamento de Fisiologia, Escola Paulista de Medicina-Universidade Federal de São Paulo, Rua Botucatu, 862-Vila Clementino, São Paulo, SP Brazil.
F P SilvaDepartamento de Fisiologia, Escola Paulista de Medicina-Universidade Federal de São Paulo, Rua Botucatu, 862-Vila Clementino, São Paulo, SP Brazil.
J CarnierDepartamento de Fisiologia, Escola Paulista de Medicina-Universidade Federal de São Paulo, Rua Botucatu, 862-Vila Clementino, São Paulo, SP Brazil.
D A de MirandaDepartamento de Fisiologia, Escola Paulista de Medicina-Universidade Federal de São Paulo, Rua Botucatu, 862-Vila Clementino, São Paulo, SP Brazil.
A B SantamarinaDepartamento de Fisiologia, Escola Paulista de Medicina-Universidade Federal de São Paulo, Rua Botucatu, 862-Vila Clementino, São Paulo, SP Brazil.
E B RibeiroDepartamento de Fisiologia, Escola Paulista de Medicina-Universidade Federal de São Paulo, Rua Botucatu, 862-Vila Clementino, São Paulo, SP Brazil.
C M Oller do NascimentoDepartamento de Fisiologia, Escola Paulista de Medicina-Universidade Federal de São Paulo, Rua Botucatu, 862-Vila Clementino, São Paulo, SP Brazil.
V V de RossoDepartamento de Biociências, Instituto de Saúde e Sociedade, Universidade Federal de São Paulo, Santos, São Paulo Brazil.
Universidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe consumption of hyperlipidic and hypercaloric diet is considered a major factor to promote obesity and the consumption of food with antioxidant properties, like Juçara (Euterpe edulis Mart), could be a tool to prevent the deleterious effect of high white adipose deposition. The aim of the present study was to evaluate the effect of administration of juçara pulp in mice fed a high-fat, high-calorie diet on glucose tolerance and adipose tissue inflammatory status.

methodsMice were distributed into the following groups: control diet; control diet plus 0.5 % of juçara; control diet plus 2 % of juçara; hypercaloric and hyperlipidic diet; hypercaloric and hyperlipidic diet plus 0.5 % of juçara and hypercaloric and hyperlipidic diet plus 2 % of juçara. Treatments started when mice were 8 weeks old and carried on for a total period of 10 weeks. The serum glucose, triacylglycerol, total cholesterol, insulin, adiponectin, lipopolysaccharides and free fatty acids concentrations were measured. Oral glucose tolerance test was performed. TNF-α, IL-6, and IL-10 protein level were determined by ELISA on mesenteric and epididymal white adipose tissues. Determination of catalase activity was realized in the same tissues. Data were analysed using one-way analysis of variance and post hoc analysis was performed with the Tukey's test.

resultsThe addition of 0.5 % juçara improved glycemic response in animals that consumed normocaloric as well as hypercaloric and hyperlipidic diets (HC). Supplementation with 0.5 and 2 % did not change the body composition of animals that received the HC diet; however, the animals fed the normocaloric diet with 2 % juçara gained body mass. An intake of 2 % juçara in the HC diet promoted a reduction of catalase activity and IL-10 level in epididymal adipose tissue.

conclusionsThese results suggest that with the administration of 0.5 % juçara, the beneficial effects of polyphenols overcome the deleterious effects of macronutrient composition of juçara, whereas with the administration of 2 % juçara promotes damage by the composition of the fruit and overshadows the beneficial effects of polyphenols on glucose metabolism. On the other hand, higher juçara supplementation improves the inflammatory status targeted by the HC diet.

Indexed as

AnthocyaninsEuterpe edulis MartInflammationJuçaraMiceObesity

Identifiers

PMID26807159
PMCPMC4722765
OpenAlexW2254932366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.